Cytokinetics CYTK Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's current debt?
- Cytokinetics (CYTK) reported current debt of $44.81M in Q1 2026.
- How has Cytokinetics's current debt changed year-over-year?
- Cytokinetics's current debt increased by 245.7% year-over-year, from $12.96M to $44.81M.
- What does current debt mean?
- The amount of long-term debt that must be paid back within the next year.
- How do you interpret current debt?
- An increase signals higher near-term refinancing risk or cash requirements for debt retirement.
- How does current debt compare across companies?
- Varies significantly based on capital structure and debt maturity profiles of peers.